Literature DB >> 10869605

Evidence for visceral hypersensitivity in high-anxiety rats.

W D Gunter1, J D Shepard, R D Foreman, D A Myers, B Greenwood-Van Meerveld.   

Abstract

In patients with irritable bowel syndrome, anxiety is often associated with visceral pain. Based on this information we hypothesized that rats genetically predisposed to anxiety have an increased visceral sensitivity. To test this hypothesis, visceromotor reflex recordings in response to colorectal distention were used to estimate the level of visceral stimulation in high; moderate-, and low-anxiety rats. We compared the effect of innocuous colorectal distension in rats with and without sensitized colons. In nonsensitized rats visceromotor responses were increased by colorectal distention with the greatest response in the high-anxiety Wistar-Kyoto strain. Sensitization of the colon significantly increased visceromotor responses to colorectal distention in all rat strains. In summary, our data suggested that a manifestation of a genetically determined anxiety level appeared to be abnormal neural responsiveness of the gastrointestinal tract leading to visceral hypersensitivity in high-anxiety animals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869605     DOI: 10.1016/s0031-9384(99)00254-1

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  36 in total

Review 1.  Centrally acting agents and visceral sensitivity.

Authors:  J Fioramonti; L Bueno
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

2.  Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.

Authors:  Maria M Buckley; Ken D O'Halloran; Mark G Rae; Timothy G Dinan; Dervla O'Malley
Journal:  J Physiol       Date:  2014-09-25       Impact factor: 5.182

3.  Natural history of comorbid orofacial pain among women with vestibulodynia.

Authors:  Eric Bair; Elizabeth Simmons; Jessica Hartung; Kinnari Desia; William Maixner; Denniz Zolnoun
Journal:  Clin J Pain       Date:  2015-01       Impact factor: 3.442

Review 4.  Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions.

Authors:  Kirsteen N Browning; R Alberto Travagli
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

5.  Importance of stress receptor-mediated mechanisms in the amygdala on visceral pain perception in an intrinsically anxious rat.

Authors:  A C Johnson; L Tran; J Schulkin; B Greenwood-Van Meerveld
Journal:  Neurogastroenterol Motil       Date:  2012-02-26       Impact factor: 3.598

Review 6.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

7.  Development of colorectal sensitization is associated with increased eosinophils and mast cells in dextran sulfate sodium-treated rats.

Authors:  J M Tobin; L M D Delbridge; R Di Nicolantonio; P Bhathal
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 8.  CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome.

Authors:  Y Taché; V Martinez; L Wang; M Million
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

Review 9.  Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.

Authors:  Maria M Buckley; Siobhain M O'Mahony; Dervla O'Malley
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

10.  Toll-like receptor mRNA expression is selectively increased in the colonic mucosa of two animal models relevant to irritable bowel syndrome.

Authors:  Declan P McKernan; Aoife Nolan; Elizabeth K Brint; Siobhain M O'Mahony; Niall P Hyland; John F Cryan; Timothy G Dinan
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.